ReviewPathogens (Basel, Switzerland)2023
Cutaneous Manifestations of
Review in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 33 citations in OpenAlex.
- The ulcer that would not heal: a rare cutaneous clue to miliary tuberculosis.Skin health and disease · 2026Article
- Successful resolution of extensive tuberculosis verrucosa cutis with local antituberculous therapy regime.JAAD case reports · 2026Article
- A 52-year-old woman with indolent verrucous plaques on a lower extremity.JAAD case reports · 2026Article
- Cutaneous Tuberculosis Presenting As Chronic Non-healing Foot Ulcer for 15 Years: A Case Report.Cureus · 2026Article
- Quality-by-Design Development of a Clofazimine-Pyrazinamide Dermal Emulsion and Its Diffusion Behavior in Strat-MPharmaceuticals (Basel, Switzerland) · 2026Article
- Cutaneous Tuberculosis in the Modern Era: A Case of Lupus Vulgaris with Surgical Management and a Review of Clinical Spectrum, Diagnostic Challenges, and Malignant Potential.Journal of clinical medicine · 2026Article
- Article
- Cracking the Skin Barrier: Models and Methods Driving Dermal Drug Delivery.Pharmaceutics · 2025Review
- Article
- Erythema Induratum as a rare manifestation of cutaneous tuberculosis in a young woman: a case report.Oxford medical case reports · 2025Article
- The Clinical Spectrum of Cutaneous Tuberculosis: A Case Series Emphasizing Prompt Recognition and Treatment.Cureus · 2025Article
- Formulation of Topical Drug Delivery Systems Containing a Fixed-Dose Isoniazid-Rifampicin Combination Using the Self-Emulsification Mechanism.Pharmaceutics · 2025Article
- Article
- Primary cutaneous mixed infection with Cryptococcus uniguttulatus and Mycobacterium tuberculosis.BMC infectious diseases · 2025Article
- Scrofuloderma of the Intermammary Area in an Adolescent Female: A Case Report.Clinical case reports · 2025Article
- Extrapulmonary Comparisons BetweenInfection and drug resistance · 2025Review
- A Rare Paradoxical Reaction in Cutaneous Tuberculosis: Insight from a Case of Lupus Vulgaris.Clinical, cosmetic and investigational dermatology · 2025Article
- The Role of mTOR inBiomedicines · 2024Review
- Unveiling a Dermatological Mystery: A Rare Case of Miliary Cutaneous Tuberculosis in an Adult Patient.Cureus · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis is an ancient disease that humanity struggled with for centuries and continues to struggle with. The bacteria
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.